Colorectal Liver Metastasis Clinical Trial
Official title:
Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study
Pts with histologically confirmed CRLM and whose CRS >2 were enrolled into this single-arm, phase II study. The critical enrollment criteria were that Subjects had completely resected Primary lesion and liver metastases and had no evidence of extrahepatic disease. After hepatectomy， HAIC (FOLFOX: oxaliplatin 85mg/m2, 5- fluorouracil 2500mg/m2, calcium folinate 400mg/m2) was given every 4-6 weeks for 2-4 cycles depending on pts' health status, in combination with Sintilimab (200mg, iv, d1) and regorafenib (80mg, po, d1-21) every 3 weeks for up to 6 months. The primary endpoint was 1-year recurrence-free survival (RFS) and secondary endpoints included RFS, overall survival (OS), safety, and health-related quality of life.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02642978 -
Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases
|
N/A | |
| Active, not recruiting |
NCT02399995 -
Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time
|
||
| Active, not recruiting |
NCT04751773 -
Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)
|
N/A | |
| Recruiting |
NCT03895723 -
Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases
|
N/A | |
| Completed |
NCT01523353 -
Prehabilitation in Liver Surgery
|
Phase 1 | |
| Recruiting |
NCT04678583 -
Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer
|
N/A | |
| Completed |
NCT02727179 -
Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases
|
N/A |